GMI: 4; GMI-S: 81; U-2; New IBD 100 leaders

The market continued to strengthen during the brief pre-holiday session. The GMI is at +4 and very close to +5 when/if the IBD growth mutual fund index turns positive.    The GMI-S is now 81, reflecting strong short term up-trends in the major indexes.  73% of the Nasdaq 100 stocks rose on Monday, along with 72% of the S&P 500 stocks and 83% of the Dow 30 stocks. Gmi0703There were 117 new highs and only 19 new lows in my universe of nearly 4,000 stocks.  13/16 stocks that hit a new high 10 days ago closed higher on Monday than they did ten days ago.  Thus, buying stocks hitting new highs has likely to have been profitable again.  35% of stocks are in an up-trend now, up from 9% on June 20. Monday was the second day in the current QQQQ up-trend.

IBD 100 growth stocks are now out-performing other stocks.  Ibd0703    81% of the IBD 100 stocks from the list on 5/15 advanced, compared with 72% of other stocks.  81% are in a bullish stage 2 up-trend and 81% closed above their critical 30 day averages.  34% of these stocks are now above their closing price on 5/15 when they were listed among the IBD 100.  Eight of these stocks hit a new high on Monday:  OII, EZPW, CLDN, XPRSA, HOC, FORM, LIFC, EXPD (I own one of these).  William O’Neil writes that the first stocks to break out of bases to new highs often become the leaders of a new bull move.  I am watching these stocks very closely….

Please send your comments to:

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.